Harrow Inc (HROW)
Harrow stock today
Harrow closed at $28.24 on October 30, 2026, down 5.84% on the day. Over the past year it returned -24.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.05 billion.
| Period | HROW | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.3% | -0.9% |
| 3 months | -27.5% | +2.1% |
| Year to date | -42.4% | +11.7% |
| 1 year | -24.8% | +12.4% |
| 3 years | +101.1% | +88.5% |
| 5 years | +179.9% | +76.0% |
Key statistics
- Market value
- $1.05B
- Forward P/E
- 17.7
- Price / sales
- 3.8
- 52-week range
- $27.24 to $54.80
- Next report
- Nov 9, 2026
About Harrow
Develops ophthalmic pharmaceuticals and surgical products.
Sector: Health Care
More on Harrow
- Financials: revenue, earnings and segmentsRevenue +36% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $9,573 today
No forecast, no recommendation. This page describes Harrow Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.